96 related articles for article (PubMed ID: 2900899)
21. [A kinetic analysis of the alpha 1-adrenergic reaction of the smooth muscles in the rat vas deferens].
Manukhin BN; Berdysheva LV; Khakimova DKh
Fiziol Zh SSSR Im I M Sechenova; 1990 Jul; 76(7):863-8. PubMed ID: 2174379
[TBL] [Abstract][Full Text] [Related]
22. Structure-activity relationships in 1,4-benzodioxan-related compounds. 4. Effect of aryl and alkyl substituents at position 3 on alpha-adrenoreceptor blocking activity.
Quaglia W; Pigini M; Tayebati SK; Piergentili A; Giannella M; Marucci G; Melchiorre C
J Med Chem; 1993 May; 36(11):1520-8. PubMed ID: 8098772
[TBL] [Abstract][Full Text] [Related]
23. Characterization of benextramine as an irreversible alpha-adrenergic blocker and as a blocker of potassium-activated calcium channels.
Plotek Y; Atlas D
Eur J Biochem; 1983 Jul; 133(3):539-44. PubMed ID: 6134617
[TBL] [Abstract][Full Text] [Related]
24. Purine nucleoside and nucleotide interactions on normal and subsensitive alpha adrenoreceptor responsiveness in guinea-pig vas deferens.
Holck MI; Marks BH
J Pharmacol Exp Ther; 1978 Apr; 205(1):104-17. PubMed ID: 204767
[TBL] [Abstract][Full Text] [Related]
25. The adrenoceptor agonist, SDZ NVI 085, discriminates between alpha 1A- and alpha 1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat.
Eltze M; Boer R
Eur J Pharmacol; 1992 Dec; 224(2-3):125-36. PubMed ID: 1361446
[TBL] [Abstract][Full Text] [Related]
26. Discrimination by SZL49 between contractions evoked by noradrenaline in longitudinal and circular muscle of human vas deferens.
Amobi NI; Guillebaud J; Kaisary AV; Turner E; Smith IC
Br J Pharmacol; 2002 May; 136(1):127-35. PubMed ID: 11976277
[TBL] [Abstract][Full Text] [Related]
27. Fluoronorepinephrines: further pharmacological evaluation in vitro and in pithed rats.
Brasili L; Cantalamessa F; Picchio MT; Quaglia W
Eur J Pharmacol; 1987 Dec; 144(2):141-6. PubMed ID: 2830122
[TBL] [Abstract][Full Text] [Related]
28. Structure-activity relationships for 2-substituted imidazoles as alpha 2-adrenoceptor antagonists.
Caroon JM; Clark RD; Kluge AF; Olah R; Repke DB; Unger SH; Michel AD; Whiting RL
J Med Chem; 1982 Jun; 25(6):666-70. PubMed ID: 6124635
[TBL] [Abstract][Full Text] [Related]
29. Two phases of contractile response in rat isolated vas deferens and their regulation by adenosine and alpha-receptors.
Major TC; Weishaar RE; Taylor DG
Eur J Pharmacol; 1989 Aug; 167(3):323-31. PubMed ID: 2572433
[TBL] [Abstract][Full Text] [Related]
30. Alpha-adrenoreceptor reagents. 3. Synthesis of some 2-substituted 1,4-benzodioxans as selective presynaptic alpha 2-adrenoreceptor antagonists.
Stillings MR; Chapleo CB; Butler RC; Davis JA; England CD; Myers M; Myers PL; Tweddle N; Welbourn AP; Doxey JC
J Med Chem; 1985 Aug; 28(8):1054-62. PubMed ID: 2862284
[TBL] [Abstract][Full Text] [Related]
31. Epinephrine enantiomers: affinity, efficacy and potency relationships in rat smooth muscle tissues.
Rice PJ; Miller DD; Patil PN
J Pharmacol Exp Ther; 1989 Apr; 249(1):242-8. PubMed ID: 2540314
[TBL] [Abstract][Full Text] [Related]
32. Differential blockade of muscarinic receptor subtypes by polymethylene tetraamines. Novel class of selective antagonists of cardiac M-2 muscarinic receptors.
Melchiorre C; Cassinelli A; Quaglia W
J Med Chem; 1987 Jan; 30(1):201-4. PubMed ID: 3806594
[TBL] [Abstract][Full Text] [Related]
33. Potentiation and inhibition of nicotinic effects on striated muscle by the tetramine disulfide benextramine.
Benfey BG; Brasili L; Melchiorre C; Belleau B
Can J Physiol Pharmacol; 1980 Aug; 58(8):984-8. PubMed ID: 6112056
[TBL] [Abstract][Full Text] [Related]
34. Demonstration of alpha 1s-adrenoceptors after exposure of the rat anococcygeus to benextramine.
Coates J; Weetman DF
Br J Pharmacol; 1983 Oct; 80(2):343-6. PubMed ID: 6140059
[TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.
Quaglia W; Pigini M; Piergentili A; Giannella M; Marucci G; Poggesi E; Leonardi A; Melchiorre C
J Med Chem; 1999 Jul; 42(15):2961-8. PubMed ID: 10425105
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and alpha-adrenoreceptor blocking properties of phenoxybenzamine-related (2-chloroethyl)-(2,3-dihydrobenzo[1,4]dioxin- 2-ylmethyl)-(2-phenoxyethyl) amines.
Giardinà D; Crucianelli M; Marucci G; Paparelli F; Melchiorre C
Bioorg Med Chem; 1995 Jan; 3(1):85-94. PubMed ID: 8612050
[TBL] [Abstract][Full Text] [Related]
37. Effect of methoxy substitution on the adrenergic activity of three structurally related alpha 2-adrenoreceptor antagonists.
Stillings MR; England CD; Welbourn AP; Smith CF
J Med Chem; 1986 Sep; 29(9):1780-3. PubMed ID: 2875186
[TBL] [Abstract][Full Text] [Related]
38. Selective blockade and recovery of cell surface alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells. Studies with the irreversible antagonist benextramine.
McKernan RM; Strickland WR; Insel PA
Mol Pharmacol; 1988 Jan; 33(1):51-7. PubMed ID: 2826999
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and structure-activity relationships of 2-sulfonamido-1,3,4,6,7,11b alpha-hexahydro-2H-benzo[a]quinolizines as alpha 2-adrenoceptor antagonists.
Ward TJ; White JF; Lattimer N; Rhodes KF; Sharma S; Waterfall JF
J Med Chem; 1988 Jul; 31(7):1421-6. PubMed ID: 2838634
[TBL] [Abstract][Full Text] [Related]
40. Benextramine-neuropeptide Y receptor interactions: contribution of the benzylic moieties to [3H]neuropeptide Y displacement activity.
Doughty MB; Chaurasia CS; Li K
J Med Chem; 1993 Jan; 36(2):272-9. PubMed ID: 8093737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
